Brian K. Roberts's most recent trade in Onto Innovation Inc. was a trade of 21,175 Common Stock done . Disclosure was reported to the exchange on Sept. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Onto Innovation Inc | Brian K. Roberts | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2025 | 21,175 | 21,175 (0%) | 0% | 0 | Common Stock | |
| Rezolute Inc | Brian Kenneth Roberts | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 4.38 per share. | 25 Jun 2025 | 2,500 | 15,500 | - | 4.4 | 10,939 | Common Shares |
| Rezolute Inc | Brian Kenneth Roberts | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 26,000 | 157,352 | - | 0 | Common Shares | |
| Rezolute Inc | Brian Kenneth Roberts | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 15,000 | 15,000 | - | - | Employee Stock Option (Right to Buy) | |
| Sensata Technologies Holding | Brian K. Roberts | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 51,074 | 111,228 (0%) | 0% | 0 | Ordinary Shares, par value EUR 0.01 per share | |
| Sensata Technologies Holding | Brian K. Roberts | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.23 per share. | 01 Apr 2025 | 2,738 | 108,490 (0%) | 0% | 24.2 | 66,342 | Ordinary Shares, par value EUR 0.01 per share |
| Rezolute Inc | Brian Kenneth Roberts | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2025 | 77,000 | 131,352 | - | 0 | Common Shares | |
| Rezolute Inc | Brian Kenneth Roberts | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2025 | 45,000 | 45,000 | - | - | Employee Stock Option (Right to Buy) | |
| Sensata Technologies Holding | Brian K. Roberts | EVP & Chief Financial Officer | 07 Nov 2024 | 774 | 60,154 (0%) | 0% | 33.5 | 25,914 | Ordinary Shares, par value EUR 0.01 per share | |
| Sensata Technologies Holding | Brian K. Roberts | EVP & Chief Financial Officer | 29 Oct 2024 | 7,442 | 60,928 (0%) | 0% | 35.3 | 262,926 | Ordinary Shares, par value EUR 0.01 per share | |
| Rezolute Inc | Brian Kenneth Roberts | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 3.91 per share. | 14 Jun 2024 | 4,000 | 54,052 | - | 3.9 | 15,640 | Common Shares |
| Rezolute Inc | Brian Kenneth Roberts | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 3.91 per share. | 14 Jun 2024 | 3,000 | 13,000 | - | 3.9 | 11,725 | Common Shares |
| Rezolute Inc | Brian Kenneth Roberts | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 3.96 per share. | 14 Jun 2024 | 300 | 54,352 | - | 4.0 | 1,188 | Common Shares |
| Rezolute Inc | Brian Kenneth Roberts | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 3.97 per share. | 14 Jun 2024 | 300 | 1,376 | - | 4.0 | 1,191 | Common Shares |
| Rezolute Inc | Brian Kenneth Roberts | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.68 per share. | 23 May 2024 | 6,000 | 50,052 | - | 2.7 | 16,058 | Common Shares |
| Rezolute Inc | Brian Kenneth Roberts | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.72 per share. | 23 May 2024 | 1,500 | 44,052 | - | 2.7 | 4,080 | Common Shares |
| Sensata Technologies Holding | Brian K. Roberts | EVP & Chief Financial Officer | 29 Apr 2024 | 41,947 | 68,370 (0%) | 0% | 0 | Ordinary Shares, par value EUR 0.01 per share | ||
| Sensata Technologies Holding | Brian K. Roberts | EVP & Chief Financial Officer | 01 Apr 2024 | 18,514 | 26,423 (0%) | 0% | 0 | Ordinary Shares, par value EUR 0.01 per share | ||
| Rezolute Inc | Kenneth Brian Roberts | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.55 per share. | 28 Mar 2024 | 500 | 1,076 | - | 2.6 | 1,275 | Common Shares |
| Rezolute Inc | Brian Kenneth Roberts | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.88 per share. | 14 Mar 2024 | 10,000 | 10,000 | - | 1.9 | 18,800 | Common Shares |
| Rezolute Inc | Brian Kenneth Roberts | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 07 Mar 2024 | 500 | 500 | - | 1.9 | 925 | Common Shares |
| Rezolute Inc | Brian Kenneth Roberts | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 07 Mar 2024 | 500 | 576 | - | 1.9 | 925 | Common Shares |
| Rezolute Inc | Roberts Brian Kenneth | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.69 per share. | 23 Feb 2024 | 6,000 | 40,552 | - | 1.7 | 10,140 | Common Shares |
| Rezolute Inc | Brian Kenneth Roberts | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.70 per share. | 23 Feb 2024 | 2,000 | 42,552 | - | 1.7 | 3,400 | Common Shares |
| Rezolute Inc | Kenneth Roberts Brian | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.31 per share. | 16 Feb 2024 | 7,000 | 34,552 | - | 1.3 | 9,142 | Common Shares |
| Rezolute Inc | Brian Roberts Kenneth | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 130,000 | 130,000 | - | - | Employee Stock Option (Right to Buy) | |
| Sensata Technologies Holding | Brian K. Roberts | EVP & Chief Financial Officer | 07 Nov 2023 | 7,909 | 7,909 (0%) | 0% | 0 | Ordinary Shares, par value EUR 0.01 per share | ||
| Rezolute Inc | Brian Kenneth Roberts | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.90 per share. | 03 Jul 2023 | 5,000 | 27,552 | - | 1.9 | 9,500 | Common Shares |
| Rezolute Inc | Brian Kenneth Roberts | Sr VP, Clinic Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 700,000 | 700,000 | - | - | Stock Option (right to buy) | |
| Rezolute Inc | Brian Kenneth Roberts | Sr VP, Clinic Development | Purchase of securities on an exchange or from another person at price $ 3.41 per share. | 17 May 2022 | 1,000 | 22,052 | - | 3.4 | 3,407 | Common Stock |
| Rezolute Inc | Brian Kenneth Roberts | Sr VP, Clinic Development | Purchase of securities on an exchange or from another person at price $ 2.95 per share. | 17 May 2022 | 300 | 22,552 | - | 2.9 | 884 | Common Stock |
| Rezolute Inc | Brian Kenneth Roberts | Sr VP, Clinic Development | Purchase of securities on an exchange or from another person at price $ 2.86 per share. | 17 May 2022 | 200 | 22,252 | - | 2.9 | 572 | Common Stock |
| Rezolute Inc | Brian Kenneth Roberts | Sr VP, Clinic Development | Purchase of securities on an exchange or from another person at price $ 3.80 per share. | 04 May 2022 | 21,052 | 21,052 | - | 3.8 | 79,998 | Common Stock |
| Rezolute Inc | Brian Kenneth Roberts | Sr VP, Clinic Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Rezolute Inc | Brian Kenneth Roberts | Sr VP, Clinic Development | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Jun 2021 | 20,000 | 0 | - | - | Stock Option (right to buy) | |
| Rezolute Inc | Brian Kenneth Roberts | Sr VP, Clinic Development | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Jun 2021 | 9,000 | 0 | - | - | Stock Option (right to buy) |